Pfizer Inc (PFE)
Total asset turnover
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 58,496,000 | 100,330,000 | 81,288,000 | 41,651,000 | 50,108,000 |
| Total assets | US$ in thousands | 227,000,000 | 197,000,000 | 181,000,000 | 154,229,000 | 167,594,000 |
| Total asset turnover | 0.26 | 0.51 | 0.45 | 0.27 | 0.30 |
December 31, 2023 calculation
Total asset turnover = Revenue ÷ Total assets
= $58,496,000K ÷ $227,000,000K
= 0.26
Pfizer Inc.'s total asset turnover ratio has shown fluctuations over the past five years. In 2023, the total asset turnover ratio was 0.26, indicating that the company generated $0.26 in sales for every $1 of assets held during the year. This represents a significant decrease from the previous year when the ratio was 0.51.
The declining trend in total asset turnover from 2022 to 2023 suggests that Pfizer may have been less efficient in utilizing its assets to generate sales revenue during this period. However, it is important to note that the total asset turnover ratio of 0.26 in 2023 is notably lower than the ratios in 2021, 2020, and 2019, indicating a possible shift in the company's asset management efficiency.
Further analysis of the factors driving this decrease in total asset turnover for Pfizer Inc. in 2023 would be necessary to determine the underlying causes and assess the implications for the company's overall financial performance and operational effectiveness.
Peer comparison
Dec 31, 2023